TY - JOUR AU - Dol, Justine AU - Aston, Megan AU - McMillan, Douglas AU - Tomblin Murphy, Gail AU - Campbell-Yeo, Marsha PY - 2022 DA - 2022/5/13 TI -参与者对每位母亲基本指导的认知-加拿大基于短信的产后项目:过程评价的随机对照试验乔- Res JMIR形式SP - e36821六世- 6 - 5 KW - mHealth KW -短信KW -产后KW -流程评估KW -移动健康KW - SMS KW -短信KW -数字医疗KW -随机对照试验KW -产后AB -背景:“基本指导每一个母亲”是一个加拿大的文本消息的程序,每天发送消息给母亲分娩后6周。有必要根据参与者的经验来探索该计划的有效性，以指导改进和修改。目的:本研究旨在通过对研究实施程度和质量的评价，描述“每位母亲必备辅导”随机对照试验的过程评价。方法:参与者在2021年1月5日至8月1日期间从加拿大新斯科舍省招募。入组的参与者被随机分为干预组和对照组。随机分配到干预组的参与者在分娩后的前6周接受了标准护理，以及“每位母亲的基本指导”项目有关新生儿和产妇护理的短信，而对照组则接受了标准护理。使用数据来自所使用的短信程序，参与者在出生后6周完成了基于网络的问卷调查。定量数据和对开放式问题的定性回答被用于三角测量结果。定量数据采用均数、SDs和百分比进行总结，定性数据采用专题分析。 Results: Of the 295 unique initial contacts, 150 mothers were eligible and completed the baseline survey to be enrolled in the study (intervention, n=78; control, n=72). Of those randomized into the intervention group, 75 (96%) completed the 6-week follow-up survey to provide feedback on the program. In total, 48 (62%) intervention participants received all messages as designed in the Essential Coaching for Every Mother program, with participants who enrolled late missing on average 4.7 (range 1-12) messages. Intervention participants reported an 89% satisfaction rate with the program, and 100% of participants would recommend the program to other new mothers. Participants liked how the program made them feel, the format, appropriate timing of messages, and content while disliking the frequency of messages and gaps in content. Participants also provided suggestions for future improvement. Conclusions: Our process evaluation has provided a comprehensive understanding of interest in the program as well as identified preference for program components. The findings of this study will be used to update future iterations of the Essential Coaching for Every Mother program. Trial Registration: ClincalTrials.gov NCT04730570; https://clinicaltrials.gov/ct2/show/NCT04730570 SN - 2561-326X UR - https://formative.www.mybigtv.com/2022/5/e36821 UR - https://doi.org/10.2196/36821 UR - http://www.ncbi.nlm.nih.gov/pubmed/35559855 DO - 10.2196/36821 ID - info:doi/10.2196/36821 ER -